Hancock Jaffe secures ethics committee approval for FIH VenoValve trial
The company selected FSFB in late June this year, as the first site for its in-human testing of its VenoValve device. FSFB owns the 205 bed University Hospital
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe company selected FSFB in late June this year, as the first site for its in-human testing of its VenoValve device. FSFB owns the 205 bed University Hospital
Patients in Pulaski County, Indiana, now have access to quiet, comfortable MR exams at Pulaski Memorial Hospital. Pulaski Memorial, a critical access facility that was previously using a
The first COE is at the Augusta Hospital Clinic for Vascular Surgery in Düsseldorf, Germany and is led by Prof. Ralf Kolvenbach, Head of the Cardiovascular Diseases Department
Cortisol is a hormone which rises and falls naturally throughout the day, but it can spike in response to stress. Presently, the methods for measuring cortisol levels require
STRATA retains all intellectual property rights related to the MelaFind device and product line, including patents, design files and PMA approval to market. The strategic entity will be
BioElectronics’ ActiPatch Therapy is an over-the-counter (OTC) treatment for back pain and other musculoskeletal complaints. The company secured pre-submission approval from the US Food and Drug Administration (US
Owen Mumford senior product manager Tania MacKenzie said: “We are delighted to be introducing the product to the European market for the first time at AIDS2018 in Amsterdam.
Bayer stated that it will not sell the product from 31st December this year, following the FDA’s patient safety action conducted in April, where the agency issued an
Aspero Medical is working on differentiated medical product for use in endoscopy procedures which result in improved performance, while saving time and money, while improving patient outcomes. The
Established in 2016 by Chris Mansi and David Golan, Viz.ai has developed, what is claimed to be the first FDA cleared computer aided triage software to detect and